Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Injured in Crash on Highway 1 Near Swanton Road


Motorcycle, Car Collide in Davenport Accident

accidentnews5

Davenport, CA (April 14, 2020) – A motorcyclist was injured in a crash in Davenport. The accident occurred on April 14 on Highway 1.

A 26-year-old motorcyclist from San Francisco illegally crossed double yellow lines to pass a Honda Pilot on Highway 1, near Swanton Road. The Honda made a left turn as the motorcyclist tried to pass it. The two vehicles collided and the motorcyclist suffered serious injuries.

#Davenport

#95017


December 24, 2019

1 Injured in Crash at Highway 14 and Agua Dulce Canyon Road

Motorcycle, Car Collide in Santa Clarita Accident...


May 8, 2020

Adolfo Sanchez Killed While Working for Lind Marine

Conveyor System Collapses in Fatal Petaluma Accident...


April 1, 2020

4 Injured in Rollover Crash on Interstate 5 Near Lurline Avenue

Car Loses Control, Goes Off Road in Williams Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.